UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

Seminars in arthritis and rheumatism, 2011-12, Vol.41 (3), p.415-423

2011

Volltextzugriff (PDF)

Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases

Frontiers in immunology, 2023, Vol.14, p.1310211-1310211

2023

Volltextzugriff (PDF)

Alteration of IgG4 levels in cerebrospinal fluid in IgG4‐related disease

International journal of rheumatic diseases, 2017-11, Vol.20 (11), p.1865-1867

2017

Volltextzugriff (PDF)

Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome

Rheumatology (Oxford, England), 2021-12, Vol.60 (12), p.5647-5658

2021

Volltextzugriff (PDF)

Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases

Journal of rheumatology, 2008-02, Vol.35 (2), p.294

2008

Volltextzugriff (PDF)

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

Clinical rheumatology, 2011-11, Vol.30 (11), p.1393-1398

2011

Volltextzugriff (PDF)

Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis

Rheumatology (Oxford, England), 2010-06, Vol.49 (6), p.1112-1117

2010

Volltextzugriff (PDF)

Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature

Medicine (Baltimore), 2008-11, Vol.87 (6), p.335-344

2008

Volltextzugriff (PDF)

Renopulmonary syndrome, importance of an early diagnosis

Medicina clinica, 2015-05, Vol.144 (9), p.430

2015

Volltextzugriff (PDF)

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Annals of the rheumatic diseases, 2016-02, Vol.75 (2), p.382-389

2016

Volltextzugriff (PDF)

Pulmonary involvement in Sjögren's syndrome

Medicina clinica, 2022-02, Vol.158 (4), p.181

2022

Volltextzugriff (PDF)

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.859-866

2015

Volltextzugriff (PDF)

Síndrome de Sjögren y afectación pulmonar

Medicina clínica, 2022-02, Vol.158 (4), p.181-185

2022

Volltextzugriff (PDF)

049. RITUXIMAB THERAPY FOR REFRACTOR/RELAPSING GRANULOMATOUS MANIFESTATIONS DUES TO GRANULOMATOSIS WITH POLYANGIITIS

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Volltextzugriff (PDF)

A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

Expert review of pharmacoeconomics & outcomes research, 2024-02, Vol.24 (2), p.227-235

2024

Volltextzugriff (PDF)

Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Influence on the Disease Outcome

Journal of rheumatology, 2020-03, Vol.47 (3), p.407

2020

Volltextzugriff (PDF)

Myositis‐specific and myositis‐associated antibodies in a series of eighty‐eight mediterranean patients with idiopathic inflammatory myopathy

Arthritis and rheumatism, 2006-10, Vol.55 (5), p.791-798

2006

Volltextzugriff (PDF)

Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?

Clinical nuclear medicine, 2022-05, Vol.47 (5), p.387

2022

Volltextzugriff (PDF)

Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal

Rheumatology (Oxford, England), 2021-10, Vol.60 (10), p.4538-4547

2021

Volltextzugriff (PDF)

Pulmonary involvement in Sjögren’s syndrome

Medicina clínica (English ed.), 2022-02, Vol.158 (4), p.181-185

2022

Volltextzugriff (PDF)

Churg–Strauss Syndrome: An evolving paradigm

Autoimmunity reviews, 2012-12, Vol.12 (2), p.235-240

2012

Volltextzugriff (PDF)

Alcoholic patient with abdominal pain and vomits

Medicina clínica, 2010-03, Vol.134 (6), p.285-285

2010

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(50)
Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Rheumatology
(30)
Middle Aged
(29)
Female
(27)
Male
(27)
Aged
(21)
Adult
(16)
General & Internal Medicine
(13)
Medicine, General & Internal
(13)
Aged, 80 And Over
(11)
Immunosuppressive Agents - Therapeutic Use
(10)
Vasculitis
(10)
Internal Medicine
(8)
Retrospective Studies
(8)
Biological And Medical Sciences
(7)
Medical And Health Sciences
(7)
Medical Sciences
(7)
Medicin Och Hälsovetenskap
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases

Alteration of IgG4 levels in cerebrospinal fluid in IgG4‐related disease

Comparison of the Birmingham Vasculitis Activity Score and the Five‐Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)

Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome

Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis

Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature

Renopulmonary syndrome, importance of an early diagnosis

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity

Pulmonary involvement in Sjögren's syndrome

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

Síndrome de Sjögren y afectación pulmonar

049. RITUXIMAB THERAPY FOR REFRACTOR/RELAPSING GRANULOMATOUS MANIFESTATIONS DUES TO GRANULOMATOSIS WITH POLYANGIITIS

A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Influence on the Disease Outcome

Myositis‐specific and myositis‐associated antibodies in a series of eighty‐eight mediterranean patients with idiopathic inflammatory myopathy

Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal

Pulmonary involvement in Sjögren’s syndrome

Churg–Strauss Syndrome: An evolving paradigm

Alcoholic patient with abdominal pain and vomits

Suchergebnisse filtern